Standardization of in vitro synthesis and detection of HIV-1-specific antibodies

J Immunol Methods. 1993 Jan 4;157(1-2):105-15. doi: 10.1016/0022-1759(93)90076-j.

Abstract

Optimal conditions for in vitro anti-human immunodeficiency virus type 1 (HIV-1) antibody (Ab) synthesis and detection were re-appraised. Western blot (WB) and radioimmunoassay (RIA) could detect about 1 and 10 ng, respectively, of HIV-1-specific Ab (HIV-Ab), while the sensitivity of an enzyme-linked immunosorbent assay (ELISA) was much lower. Optimal HIV-Ab recovery was obtained by culturing 2.5 x 10(6) peripheral blood mononuclear cells (PBMC)/ml from seropositive subjects for 16 days in the absence of mitogens; at higher cell concentrations, background levels were unacceptably high. The background of non-de novo synthesized HIV-Ab was due to insufficient PBMC washing and/or cytophilic immunoglobulin (Ig); a particular washing procedure, as well as 24 h peripheral blood mononuclear cells (PBMC) pre-culture, might help in limiting this phenomenon. However, results should be compared with those obtained in cultures containing puromycin especially in infants, where a higher CD16 antigen expression in lymphocytes is likely responsible for increased amounts of cytophilic Ig released in culture supernatants, compared to adults.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Blotting, Western
  • Cells, Cultured
  • HIV Antibodies / analysis*
  • HIV Antibodies / biosynthesis*
  • HIV-1 / immunology*
  • Humans
  • Immunoglobulins / analysis
  • Infant
  • Radioimmunoassay
  • Receptors, Fc / physiology

Substances

  • HIV Antibodies
  • Immunoglobulins
  • Receptors, Fc